Aripiprazole monotherapy in acute bipolar I mania: A randomized, placebo- & lithium-controlled study (Cn138-135)

被引：0
|
作者：
Hanssens, L. [1 ]
Torbeyns, A. [1 ]
Marcus, R. N. [2 ]
McQuade, R. D. [3 ]
Sanchez, R. [4 ]
机构：
[1] Bristol Myers Squibb Co, Braine LAlleud, Belgium
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] Bristol Myers Squibb Co, Rueil Malmaison, France
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.416
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [11] A 52-week, double-blind safety and efficacy evaluation of aripiprazole monotherapy versus lithium in bipolar I disorder (CN138-135LT)
    El Mallakh, R. S.
    Marcus, R. N.
    Baudelet, C.
    McQuade, R. D.
    Carson, W. H.
    Owen, R.
    BIPOLAR DISORDERS, 2009, 11 : 36 - 36
  • [12] Aripiprazole vs placebo for the treatment of acute mania in patients with bipolar I disorder
    Carson, W
    Sachs, G
    Sanchez, R
    Marcus, R
    Kujawa, M
    Archibald, D
    Iwamoto, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S332 - S332
  • [13] A 46-week evaluation of aripiprazole in combination with lithium/valproate in bipolar mania (CN138-134)
    Vieta, E.
    Baudelet, C.
    McQuade, R. D.
    Marcus, R. N.
    Sanchez, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S447 - S447
  • [14] A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania
    Weiser, Mark
    Levi, Linda
    Levine, Stephen Z.
    Bialer, Meir
    Shekh-Ahmad, Tawfeeq
    Matei, Valentin
    Tiugan, Alexandru
    Cirjaliu, Diana
    Sava, Cristinel
    Sinita, Eugenia
    Zamora, Daisy
    Davis, John M.
    BIPOLAR DISORDERS, 2017, 19 (04) : 285 - 294
  • [15] A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder
    Bowden, CL
    Grunze, H
    Mullen, J
    Brecher, M
    Paulsson, B
    Jones, M
    Vågerö, M
    Svensson, K
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 111 - 121
  • [16] EFFICACY OF ADJUNCTIVE ARIPIPRAZOLE TO LITHIUM OR VALPROATE IN THE LONG-TERM TREATMENT OF MANIA IN SUBJECTS WITH BIPOLAR I DISORDER (CN138-189)
    Abbar, M.
    Khan, A.
    Rollin, L.
    Sanchez, R.
    Carson, W.
    Morris, B.
    Timko, K.
    Marcus, R.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [17] Placebo effect in randomized, controlled studies of acute bipolar mania and depression
    Keck, PE
    Welge, JA
    McElroy, SL
    Arnold, LM
    Strakowski, SM
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 748 - 755
  • [18] A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania
    Keck, PE
    Marcus, R
    Tourkodimitris, S
    Ali, M
    Liebeskind, A
    Saha, A
    Ingenito, G
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (09): : 1651 - 1658
  • [19] Aripiprazole in acute mania: Results from a second placebo-controlled study
    Scott, K
    Sanchez, R
    Marcus, R
    Saha, A
    Gharbia, NA
    Archibald, DG
    Iwamoto, T
    EUROPEAN PSYCHIATRY, 2004, 19 : 204S - 204S
  • [20] Aripiprazole in acute mania: results from a second placebo-controlled study
    Hadjakis, WJ
    Marcus, R
    Abou-Gharbia, N
    Tourkodimitris, S
    Archibald, DG
    Carson, WH
    Iwamoto, T
    Sanchez, R
    BIPOLAR DISORDERS, 2004, 6 : 39 - 40
12345